Your Search Results

Lifetime management of patients with aortic stenosis and expanding indication of TAVI - What do we need to know next?

TAVI patients are getting younger and younger, and are becoming less and less risky, so it is becoming essential to know how to manage lifetime and follow-up of patients with aortic stenosis, how to manage prosthesis degeneration, and perform TAVI-in-TAVI or TAVI explant. Thanks to this...

Transcatheter repair for complex degenerative mitral regurgitation - LIVE case

18 Feb 2023 – From PCR Tokyo Valves 2023

An 83-year-old female with chronic kidney disease, RBBB, has severe mitral regurgitation due to P2 prolapse and preserved LV function (69 %).

The operators decide to implant 1 XTW clip, guided by TEE and left atrial pressure.

LIVE Case from Kokura Memorial Hospital Kitakyushu, Japan

Navigate the video by...

Transcatheter repair for complex degenerative mitral regurgitation

My worst nightmare - Mitral valve intervention

18 Feb 2023 – From PCR Tokyo Valves 2023

Through the three challenging cases presented in this session, each presenting an access, leaflet and clip nightmare, learn about optimal bailout and prevention methods to deal with these rare complications that can occur during transcatheter mitral valve intervention.

My worst nightmare - Mitral valve intervention

TAVI in a patient with heavily calcified valve anatomy - LIVE case

18 Feb 2023 – From PCR Tokyo Valves 2023

An 80-year-old male with chronic kidney disease and interstitial pneumonia treated under steroids presented a symptomatic severe aortic stenosis with massive calcifications on the valves and only on the valves (not the LVOT).
Watch the operators implant a Sapien 3 23 mm (-1cc) with a predilatation (Balloon...

TAVI in a patient with heavily calcified valve anatomy

Future devices and techniques

19 Feb 2023 – From PCR Tokyo Valves 2023

In this session, find out more about TMVR device options and trial updates, a case of severe mitral regurgitation treated with TMVR, ongoing trials and future innovations regarding transcatheter tricuspid valve repair and replacement, and much more!

My worst nightmare in TAVI

Listen to our experts share their most nightmarish TAVI cases and follow the debate around their treatments. For instance, would you make the same choices when faced with a 76-year-old female patient diagnosed as severe AS, transferred for SAVR/TAVI, who got a new Abif and cardiogenic...

PCR Tokyo Valves 2023 Closing Ceremony

19 Feb 2023 – From PCR Tokyo Valves 2023

This closing ceremony of the 2023 edition of the PCR Tokyo Valves is the occasion to unveil the results of the best abstract and best case competitions and to congratulate the finalists. It is also the moment to take stock of this excellent edition, to thank...

TAVI in small annulus and coronary artery disease - Session with LIVE case

19 Feb 2023 – From PCR Tokyo Valves 2023

Watch the complex case of an 84-year-old woman with hypertension, type 2 diabetes and coronary artery disease who presented with worsening NYHA class II-III exertional dyspnoea, but no angina, and find out how she was treated LIVE.

The optimal first valve choice for all patients with aortic stenosis

18 Feb 2023 – From PCR Tokyo Valves 2023

How have advances in TAVI impacted the lifetime journey of patients with aortic stenosis? Join this panel of experts as they discuss the importance of optimizing the first procedure and the key issues regarding treatment options in patients with bioprosthetic valve deterioration of transcatheter heart valve.

How to optimise the lifetime management of TAVI patients with long-life expectancy?

18 Feb 2023 – From PCR Tokyo Valves 2023

This session addresses three essential elements of a successful TAVI procedure: the impact of valve design on long-term durability, how to mitigate the risk of paravalvular leakage, and the importance of the possibility for coronary access after TAVI.

Remaining unmet needs and strategies in TAVI

19 Feb 2023 – From PCR Tokyo Valves 2023

This session focuses on valve design and durability performance in TAVI for patients with aortic stenosis, and the way it impacts future patient outcomes.